A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/20/2011	US20110256149 Antibody formulation
10/20/2011	US20110256138 Amyloid-beta binding proteins
10/20/2011	US20110256136 Complement Inhibitors For Treatment Of Injury From Intracerebral Hemorrhage
10/20/2011	US20110256135 Anti-nerve growth factor (ngf) antibody compositions
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256121 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/20/2011	US20110256120 Methods and Compositions for Reducing Amyloid Beta Levels
10/20/2011	US20110256107 Treatment of brain damage using umbilical cord blood cells
10/20/2011	US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle
10/20/2011	US20110256096 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
10/20/2011	US20110256070 Pharmaceutical compositions and methods for administering the same
10/20/2011	US20110256066 Method for preparing engineered mg doped ferrite superparamagnetic nano particle exhibiting ac magnetic induction heating at high temperature and mg doped ferrite superparamagnetic nano particles engineered by the method
10/20/2011	US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011	US20110256062 Methods
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110253135 Metal coordination complexes of volatile drugs
10/20/2011	CA2796575A1 Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
10/20/2011	CA2796215A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	CA2796150A1 Statins for the prevention or treatment of drug addictions
10/20/2011	CA2795408A1 Methods for producing viloxazine salts and novel polymorphs thereof
10/20/2011	CA2794808A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/20/2011	CA2790687A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
10/20/2011	CA2786216A1 Arylethynyl derivatives
10/19/2011	EP2377886A1 Antibody glycosylation in the variable region
10/19/2011	EP2377875A1 Antioxidant
10/19/2011	EP2377865A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/19/2011	EP2377860A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/19/2011	EP2377853A1 7,11-Methanocycloocta[b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
10/19/2011	EP2377852A1 Labelled huprine derivatives and their use in medical imaging
10/19/2011	EP2377578A1 Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof
10/19/2011	EP2377535A1 Method and composition for treating multiple sclerosis (variants)
10/19/2011	EP2377533A2 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
10/19/2011	EP2377531A2 Neurogenesis by modulating angiotensin
10/19/2011	EP2377530A2 Modulation of neurogenesis by PDE inhibition
10/19/2011	EP2376512A2 Derivatives of morphine-6-glucuronid, process for their preparation and their use in therapy
10/19/2011	EP2376511A2 Bicyclic derivatives of morphine-6-glucuronid, process for their preparation and their application in therapy
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP2376496A2 Synthesis of morphine-6-glucuronide or of a derivative thereof
10/19/2011	EP2376486A1 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/19/2011	EP2376463A1 Benzothiazole amides for detection of amyloid beta
10/19/2011	EP2376457A2 Crystalline salt forms of flibanserine
10/19/2011	EP2376455A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
10/19/2011	EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011	EP2376083A1 Quinazoline inhibitors of bace 1 and methods of using
10/19/2011	EP2376072A1 Arginase inhibitors for the treatment of depression
10/19/2011	EP2375900A1 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
10/19/2011	EP2276759B1 3-indazolyl-4-pyridylisothiazoles
10/19/2011	EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011	EP2018380B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
10/19/2011	EP1993587B1 Use of the engrailed homeodomain protein as an anxiolytic
10/19/2011	EP1967195B1 Antacid
10/19/2011	EP1966209B1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
10/19/2011	EP1923387B1 Acylguanidine derivative or salt thereof
10/19/2011	EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/19/2011	EP1735332B1 Azacyclosteroid histamine-3 receptor ligands
10/19/2011	EP1694334B1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1499321B1 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect")
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1233966B2 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN1496404B Materials and methods relating to protein aggregation in neurodegenerative disease
10/19/2011	CN102224168A Composition for producing anti-amyloid beta peptide antibodies with d-peptides
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102224138A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
10/19/2011	CN102224136A 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/19/2011	CN102224135A Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
10/19/2011	CN102223887A Method for treating parkinson's disease
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102223883A Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
10/19/2011	CN102220324A SiRNA for inhibiting gene expression of caspase-3
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102219826A Polymorphs of sarsapogenin
10/19/2011	CN102219783A Vilazodone hydrochloride and composition thereof
10/19/2011	CN102219752A Novel crystal form D of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
10/19/2011	CN102219720A Novel selenic acid biological material with anti-aging function
10/19/2011	CN102218146A ShRNA (Short Hairpin Ribonucleic Acid) kit for treating animal model suffered from alzheimer disease
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218137A Vaccine
10/19/2011	CN102218128A Health-care medicinal tea and its preparation method
10/19/2011	CN102218117A Fire treatment liquid embrocation for external application and preparation method thereof
10/19/2011	CN102218115A Health care traditional Chinese medicine for drivers
10/19/2011	CN102218107A Chinese traditional medicament c composition for treating insomnia
10/19/2011	CN102218096A Composition for relieving the effects of alcohol and preventing hangover and disintoxicating drink having the composition
10/19/2011	CN102218091A Application of cinnamon oil, cinnamyl aldehyde and derivatives of cinnamyl aldehyde in preparation of histamine H3 acceptor antagonist or inverse agonist medicaments
10/19/2011	CN102218090A Rice roasting processing method of traditional Chinese medicine salvia miltiorrhiza bunge
10/19/2011	CN102218076A Apostichopus japonicus polysaccharides, and application thereof in preparation of medicament or food for preventing and treating senile dementia
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218067A Use of oxicam compounds
10/19/2011	CN102218066A Application of ligustrazine in preparation of medicaments for preventing and treating depression
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218055A Medicament for treating Alzheimer disease(AD)
10/19/2011	CN102218050A Pharmaceutical composition for treating depression
10/19/2011	CN102218049A Anti-ageing medicine or health care food composition and application
10/19/2011	CN102218044A Enhanced immediate release formulations of topiramate
10/19/2011	CN102218042A Sustained release tablet of quetiapine fumarate composition and preparation method of sustained release tablet

1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 1833